Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3909088 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL29941787 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| Tetraethylene Glycol SCHEMBL23524451 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL14948191 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL61549 | 0.97 | — | — | |
| Di(Hydroxyethyl)Ether SCHEMBL1859973 | 0.97 | TSHR (0.67) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL23524458 | 0.97 | TSHR (0.67) | MEN1KMT2ATSHRMAPK1THRB | |
| Ammonia Solution, Strong SCHEMBL28254082 | 0.94 | — | — | |
| SCHEMBL28142567 | 0.94 | — | — | |
| Tetraethylene Glycol SCHEMBL28289692 | 0.90 | MEN1 (0.73) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180271423-A1 | A BIOSENSOR DEVICE TO DETECT TARGET ANALYTES IN SITU, IN VIVO, AND/OR IN REAL TIME, AND METHODS OF MAKING AND USING THE SAME | THE UNIVERSITY OF TOLEDO (US) | 2018-09-27 | — | — | US | claimed |
| EP-1855340-B1 | COOLANT COMPOSITION FOR FUEL CELL | SHISHIAI KK (JP) | 2011-09-07 | — | — | EP | claimed |
| US-20080251756-A1 | COOLANT COMPOSITION FOR FUEL CELL | SHISHIAI-KABUSHIKIGAISHA (JP) | 2008-10-16 | — | — | US | claimed |
| EP-1855340-A1 | COOLANT COMPOSITION FOR FUEL CELL | Shishiai-Kabushikigaisha (JP) | 2007-11-14 | — | — | EP | claimed |
| EP-4731257-A1 | CONJUGATES OF SAPONIN AND ANTISENSE OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | Sapreme Technologies B.V. (NL) | 2026-04-29 | — | — | EP | disclosed |
| EP-4731261-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | Sapreme Technologies B.V. (NL) | 2026-04-29 | — | — | EP | disclosed |
| CN-119744179-A | Conjugates for targeted therapy | 梁碧惠 | 2025-04-01 | — | — | CN | disclosed |
| WO-2024261044-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | SAPREME TECHNOLOGIES B.V. (NL) | 2024-12-26 | — | — | WO | disclosed |
| WO-2024261042-A1 | CONJUGATES OF SAPONIN AND ANTISENSE OLIGONUCLEOTIDES FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | SAPREME TECHNOLOGIES B.V. (NL) | 2024-12-26 | — | — | WO | disclosed |
| US-20230310618-A1 | CONJUGATE FOR TARGETING THERAPY | NATIONAL TAIWAN UNIVERSITY (TW) | 2023-10-05 | — | — | US | disclosed |
| CN-108372459-B | Chemical mechanical polishing method for tungsten | 罗门哈斯电子材料CMP控股股份有限公司 | 2020-04-21 | — | — | CN | disclosed |
| US-10286518-B2 | Chemical mechanical polishing method for tungsten | ROHM AND HAAS ELECTRONIC MATERIALS CMP HOLDINGS, INC. (US) | 2019-05-14 | — | — | US | disclosed |
| WO-2006100188-A9 | ANTIWEAR LUBRICANT COMPOSITIONS FOR USE IN COMBUSTION ENGINES | CIBA SC HOLDING AG (CH) | 2008-02-28 | — | — | WO | disclosed |
| US-20080039816-A1 | Carbohydrate-Encapsulated Quantum Dots for Bilogical Imaging | The Government of the United States of America as represented by the Secretary, Department of (US) | 2008-02-14 | — | — | US | disclosed |
| WO-2006127675-A2 | NANOPARTICLES AND METHOD TO CONTROL NANOPARTICLE SPACING | STATE OF OREGON ACTING BY & THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 2006-11-30 | — | — | WO | disclosed |
| EP-1041100-B1 | PROCESSES FOR PRODUCING POLYOXYALKYLENE POLYOL AND PRODUCING DERIVATIVE THEREOF | MITSUI CHEMICALS INC (JP) | 2006-01-18 | — | — | EP | disclosed |
| WO-2005093422-A2 | CARBOHYDRATE-ENCAPSULATED QUANTUM DOTS FOR BIOLOGICAL IMAGING | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-10-06 | — | — | WO | disclosed |
| WO-2005010481-A2 | PREPARATION AND USE OF GOLD GLYCONANOPARTICLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-02-03 | — | — | WO | disclosed |
| US-6410676-B1 | USING PHOSPHAZENIUM CATALYST | MITSUI CHEMICALS, INC. (JP) | 2002-06-25 | — | — | US | disclosed |
| EP-1041100-A1 | PROCESSES FOR PRODUCING POLYOXYALKYLENE POLYOL AND PRODUCING DERIVATIVE THEREOF | Mitsui Chemicals, Inc. (JP) | 2000-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310618-A1 | CONJUGATE FOR TARGETING THERAPY | FOLH1, CD44, SLC10A1 | MEN1 439/4885KMT2A 608/4885TSHR 1876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.